Kush Parmar, Director, 10% Owner at Entrada Therapeutics, Inc. (TRDA), sold 116,474 shares at $6.93 ($807K) on 2026-07-30, disclosed to the SEC on 2026-08-03.
Open-market sale of $807k TRDA by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.93 | 114,756 | $795K | 98.5% |
| 2 | $6.85 | 1,718 | $12K | 1.5% |
| Total | $6.93 avg | 116,474 | $807K | 100% |
| Filing → |
| TRDA | SELL | 2025-07-11 | $405K | — | Filing → |
| TRDA | SELL | 2025-07-01 | $1.6M | — | Filing → |
| SKYE | BUY | 2024-03-15 | $4.5M | — | Filing → |